e- tender for rate contract for supply of jssk medicine and surgical ltems dist-sikar , jssk drugs and consumables , tab . iron folic acid-large-dried ferrous sulphate ip eq . to ferrous iron 100mg & folic acid ip 0 . 5mg as enteric coated tablets , tab . methyldopa ip eq . to methyldopa anhydrous 250mg , cap nifedipine-nifedipine ip , 5mg soft gelatine capsule , tab nifedipine , nifedipine ip , 10mg , tab labetalol 100mg , inj labetalol , 20mg in 2ml ampoule , tab digoxin-digoxin ip 250mg/tab , inj magsulph-magnesium sulphate ip 50% w/v , 10ml vials , containing 5 . 0mg in total volume , tab . folic acid ip 5mg , cap ampicillin-ampicillin trihydrate ip eq . to ampicillin 500mg , inj gentamycin- gentamycin sulphate ip eq . to gentamycin 40mg/ml; 2ml in each vial , ampicillin injection-ampicillin sodium ip eq . to ampicillin anhydrous 500mg/vial , cap amoxycillin-amoxycilline trihydrate ip eq . to amoxycilline 250mg , tab . metronidazole-metronidazole ip 400mg , tab nitrofurantoin- ip 100mg , cap doxycycline-doxycycline hydrochloride ip eq . to doxyxycline 100mg , inj methylergometrine-methylergometrine maleate ip , 0 . 2mg/ml , 01ml in each ampoule , tab misoprostol- misoprostol ip 200 mog oral/vaginal , tab dicyclomine , 10mg oral tab , inj magnesium sulphate- magnesium sulphate ip 50% w/v; 10ml vials , containing 5 . 0gm in total volume , inj oxytocin- oxytocin ip 5 . 0 i . u . /ml; 01 ml in each ampoule , inj . hyoscine butyl bromide 20mg in 1 ml ampoule , tab hyoscine butyl bromide 10mg , menadione injection ( vitamin k3 ) menadione usp 10mg/ml; 01 ml in eachampoule ) , compound sodium lactate iv indection ip ( ringers lactate ) -0 . 24%v/v of lactic acid ( eq . to 0 . 32%w/vof sodium lactate ) , 0 . 6%w/v sodium chloride , 0 . 04% w/v potassium chloride and 0 . 027%w/v;500ml in each plastic bottle , sodium chloride iv injection-sodium chloride ip 0 . 9%w/v; 500ml in each plastic bottle , dextrose iv indection , ip- dextrose eq . to dextrose anhydrous 5% of w/v , 500ml in each plastic bottle , sodium bicarbonate , iv injection-sodium bicarbonate ip 7 . 5% w/v , 10ml in each ampoule , sterile water for injections , i . p-05 ml in each ampoul , inj . calcium gluconate , 1 gm , i . v . -10ml amp containing 10% calcium gluconate , tab drotavarine 40mg , povidone iodine ointement , ip containing povidone lodine , ip 5% w/w; 15g in each tube , inj . lignocaine hydrochloride ip 2% w/v; 30ml in each vial for local anaesthesia , povidone lodine solution 5% , disposable examination glove latex free size-6 . 0 , 6 . 5 , 7 . 0 , surgical gloves sterile bis size 7 . 5 , hppodermic syringe for single use bp/bis , 5ml , 10ml , 20ml , hypodermic needle for single use bp/bis , gauze 23 and 22 , absorabent gauze , surgical spririt , b . p . 500ml in each bottle , infusion equipment bis , iv set with hypodermic needle , 21g of 1 . 5 inch length , intra-cath cannulas for single use ( indracascular catheters ) bis auze 18 , length-45mm , flow rate 90ml per minutes gauze 22 , length-25mm , flow rate 35ml per minutes , chromic catgut no-1 on round body needle r-7/r-13 , cord clamp , mucus sucker , medicated soap , k-90 , plain catheter , foleys catherter , 16 no bis , self retaining catheter , sanitary napkins ( 2pkts per case ) , tab . iron folic acid-large- dried ferrous sulphate ip eq to ferrous iron 100mg & folic acid ip 0 . 5 mg as enteric coated tables , tab digoxin - digoxin ip 250 mg/tab , tab methyldopa ip eq . to methyldopa anhydrous 250mg , cap nifedipine-nifedipine ip , 5mg soft gelatine capsule , tab nifedipine , nifedipine ip , 10mg , tab labetalol 100mg , inj . labetalol , 20mg in 2ml ampoule , in . oxytocin-oxytocin ip 5 . 0 . 1 . u/ml ; 01ml in each ampoule , inj magsulph-magnesium sulphate ip 20% w/v; 10ml vials . contaning 5 . 0gm in total volume , hydroxyethyle starch 6%ip -hydroxyethyle starch 130/04 . 6% saline solution for infusion , tab paracetamol , ip 500mg , tab ibubrufen 400mg , tab/cap , multivitamin , tab domperidone 10mg , anti d immunoglobulin-inj polyclonal human anti rhd immunoglobulin 100mg , 300mg , inj . metronidazole-metronidazole ip 5mg/ml: 100ml in each bottle , inj . gentamycin-gentamycin sulphate ip eq . to gentamycin 40mg/ml; 02ml in each vial , inj . cefotaxime - cefotaxime sodium ip 1gm per vial , inj . cloxacillin-cloxacillin sodium ip eq . to cloxacillin 500mg/vial , inj . oxytocin-oxytocin ip 5 . 0 . i . u . /ml; 01ml in each ampoule , inj . sensorcain , containing sensorcain i . p . 0 . 5mg , inj . lignocaine hydrocloride ip 5% w/v; lignocaine hydrocloride 50mg/ml with 7 . 5% dextrose hyperbaric ( heavy ) , 02ml in each ampoule hyperbaric for spinal anaesthesia , inj . lignocaine hydrochloride ip 2% w/v; 30ml in each vial for local anaesthesia , inj . promethazine , ip promethazine hydrochloride 25mg/ml; 2ml in each ampoule , compound sodium lactate iv injection ip ( pingers lactate ) -0 . 24%v/v of lactic acid ( eg . to . 32%w/v of sodium lactate ) , 0 . 6% w/v sodium chloride 0 . 04% w/v potassium chloride and 0 . 027% w/v calcium chloride; 500ml in each plastic bottle , sodium chloride iv injection- sodium chloride ip 0 . 9% w/v 500ml in each plastic bottle , dextrose iv injection -dextrose eq . to dextrose anydrous 5% w/v 500ml in each plastic bottle , inj soda bicarbonte-doduum bicarbonate ip 7 . 5% w/v; 01ml in each ampoule , inj menadione ( vitamin k3 ) - menadione usp 10mg/ml; 01ml in each ampoule ) , inj . pentazocine lactate ip pentazocine lactate . ip eq . to pentazocine 30mg per ml; 1ml in each ampoule , povidine lodine solution , sticking plaster ( surgical tape ) -2 . 5cmx9 . 10m , hypodermic syringe for single use bp/bis , 5ml , 10ml , 20ml , hypodermic needle for single use bp/bis , gauze 23 and 22 , foleys catheter 16 no bis , self retaining catherter , infusion equipment bis , iv set with hypodermic needle , 21 g of 1 . 5 inch length intra cath cannulas for single use ( intravascular catherters ) bis gauze 18 , length-45mm , fiow rate 90ml per minute gauze 22 , length 25mm flow rate 35ml per minute gauze20 , length 33mm , gauze 16 , chromic catgut no . 1 on round body needle , no . 2-0 on round body needle r-7/r-13 , cord clamp , suction tupe , spine needle disposable adult as per bis , 23 gauze ( 70-90mm without hub ) , medicated soap , k-90 plain catherter , foleys catheter 16 no bis , self retaining catheter , urobag , sponges , absorbent gauze , surgical spirit , b . p 500ml in each bottle , mucus sucker , mersilk no 2-0 , 1-0 on cutting needle , polyglycolic acid , braided , coated and absorbable , no . 1 on 1/2 circle round body needle , inj . adrenaline -0 . 18% w/v of adrenaline tartrate or adernaline tartrate ip eq . to adrenaline 1mg/ml; 01ml in each ampoule , inj . atropine . ip- atropine sulphate ip 600mg/ml; 01ml in each ampoule , inj . dopamine -dopamine hydrochloride usp 40mg/ml: 05ml in each vial , inj . bupivacaine- 0 . 5% ip eq . to bupivacaine hydrocloride anhydrous 5mg/ml; 20ml in each vial , inj . betamethasone sod . phosphate , ip betamethasone 1mg per 1ml in 1ml ampoule , halothane i . containing 0 . 01% w/w thymol ip; 200ml in each bottles , inj . thiopentone . thiopentone 500mg and sodium carbonate ( anhydrous ) , inj . vecuronium bromide , vecuronium bromide usp 1mg per ampoule , inj . ketamine -ketamine hydrochloride inj . eq . to ketamine hydrochloride base 10mg/ml; 10ml in each vial , tab salbutamol- salbutamol sulphate ip eq . to salbutamol 4mg , tab frusemide- frusemide ip 40mg , tab diazepam - diazepam ip 5mg , inj . diazepam , ip-10mg in 2ml ampoule , dexmethsone injection ip , dexamethasone sodium phosphate ip eq . to dexamethasone phosphate . 4mg/ml: 02ml in each ampoule , etofyllin b plus , anhydrous theophylline ip combination injection , etofylline p 84 . 7mg/ml & theophylline ip eq . to theophylli